Navigation Links
Jazz Pharmaceuticals, Inc. Announces Fourth Quarter and Full Year 2009 Financial Results
Date:3/3/2010

#160;Jazz Pharmaceuticals' actual results and the timing of events could differ materially from those anticipated in such forward looking statements as a result of these risks and uncertainties, which include, without limitation, risks related to: Jazz Pharmaceuticals' ability to increase sales of its XYREM and LUVOX CR products; Jazz Pharmaceuticals' dependence on single source suppliers and manufacturers; the uncertain and time-consuming regulatory approval process for JZP-6; Jazz Pharmaceuticals' ability to successfully market JZP-6 in the U.S. if approved by the FDA for the treatment of fibromyalgia; Jazz Pharmaceuticals' cash flow estimates, the sufficiency of its cash resources and the potential need to raise additional funds; competition, including from potential generic competitors; Jazz Pharmaceuticals' future financial performance and financial position; and those risks detailed from time-to-time under the caption "Risk Factors" and elsewhere in Jazz Pharmaceuticals' Securities and Exchange Commission filings and reports, including in its Registration Statement on Form S-1 (File No. 333-163999) filed by Jazz Pharmaceuticals with the Securities and Exchange Commission on December 23, 2009.  Jazz Pharmaceuticals undertakes no duty or obligation to update any forward-looking statements contained in this release as a result of new information, future events or changes in its expectations.

    
    
                            JAZZ PHARMACEUTICALS, INC.                        
                       CONSOLIDATED STATEMENTS OF OPERATIONS                  
                     (In thousands, except per share amounts)                 
                                    (Unaudited)                               
                                                                              
                                                                              
                                       
'/>"/>
SOURCE Jazz Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

Related medicine technology :

1. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
2. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
3. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
4. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
5. Sucampo Pharmaceuticals, Inc. Begins Pivotal Phase III Studies of Oral Lubiprostone to Treat Opioid-Induced Bowel Dysfunction (OBD)
6. Symbollon Pharmaceuticals, Inc. Evaluates the Clinical Effects of IoGen(TM) on Fibrocystic Breast Disease
7. Aegerion Pharmaceuticals, Inc. Presents Final Results of Phase II Clinical Trials for AEGR-733 at Drugs Affecting Lipid Metabolism (DALM) 2007 Conference
8. Keryx Biopharmaceuticals, Inc. Announces Positive Preliminary Phase 2 Data on KRX-0401 in Patients with Chemo-Insensitive Rare Sarcoma
9. Quark Pharmaceuticals, Inc. Announces First Systemic siRNA Dosing in Humans
10. Keryx Biopharmaceuticals, Inc. Announces Phase 1 and Phase 2 Data on KRX-0401 (Perifosine) in Patients with Relapsed/Refractory Multiple Myeloma at 49th Annual Meeting of American Society of Hematology
11. Solvay Pharmaceuticals, Inc. Responds to Advisory Committee Recommendation for Further Study of Tedisamil to Treat Atrial Fibrillation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... , July 23, 2014  The management team ... ) will hold a conference call on July ... second quarter ended June 30, 2014.  The call ... 2014Time: , 8:30 am EDTDial-in numbers: , Toll ... (412) 317-0790Webcast (live & archive): , www.columbialabs.com ...
(Date:7/23/2014)... -- Global healthcare company GSK reports Q2 ... increased price competition and supply disruptions to its Consumer ... points out that the company is very much in transition, ... confident about long-term prospects as well as the investments ... Simon Dingemans adds that the company is ...
(Date:7/23/2014)... , July 23, 2014 Research ... the "Prepackaged Medical Kits and Trays - ... offering. http://photos.prnewswire.com/prnh/20130307/600769 ... for Prepackaged Medical Kits and Trays in US$ ... Trays, Ophthalmic Custom Trays, Custom Basin Kits, Custom ...
Breaking Medicine Technology:Columbia Laboratories to Discuss Second Quarter 2014 Financial Results on July 31st Conference Call 2Prepackaged Medical Kits and Trays - Global Strategic Business Report: Updated 2014 Report 2
... Club (FC) Barcelona, FC Barcelona Foundation, and ... three-year partnership today to energize the global fight to ... life-saving vaccines.  Bill Gates, co-chair of the Bill & ... Rosell and Manager Josep Guardiola, announced the partnership at ...
... this week at the American Association for Clinical Chemistry (AACC) ... and that testing individuals at risk may be beneficial. ... Health and Nutrition Survey, reported in the Archives of ... D levels over 30 nanogram/millilitre (ng/mL), a level that many ...
Cached Medicine Technology:Futbol Club Barcelona and the Bill & Melinda Gates Foundation Team Up to End Polio and Give Every Child an Equal Shot at Life 2Futbol Club Barcelona and the Bill & Melinda Gates Foundation Team Up to End Polio and Give Every Child an Equal Shot at Life 3Data Presented at American Association for Clinical Chemistry Meeting Show Many Americans May Have Low Vitamin D Levels 2Data Presented at American Association for Clinical Chemistry Meeting Show Many Americans May Have Low Vitamin D Levels 3
(Date:7/23/2014)... 23, 2014 Rich Dad® Education, a leader ... their charity yard sale to support Habit for Humanity of ... of the proceeds will be donated to Habitat for Humanity. ... being donated to the Habitat for Humanity ReStore thrift store ... , One of the highlights of the yard sale ...
(Date:7/23/2014)... 2014 Global Cardio Care, Inc., a ... Counterpulsation (EECP), is celebrating the 100th birthday of ... the health center. , Weber has been plagued ... ongoing EECP therapy since 1999, he no longer suffers ... of Global Cardio Care, introduced the Sara Soulati ...
(Date:7/23/2014)... (PRWEB) July 23, 2014 Bodybuilding.com, the ... online retailer of nutritional supplements, has officially opened the ... BPI SPORTS , the fastest growing sports nutrition company, ... , Brand of the Year, Best Tasting Protein of ... Protein Powder of the year - Whey-HD™, Pre-workout Supplement ...
(Date:7/23/2014)... treating the pernicious disorders of obesity and dementia reside ... University,s Center for Behavioral Neuroscience. In the paper, researchers ... at areas of the brain responsible for memory and ... play a role in reducing certain dementias., "In the ... often fall short. This is a new way for ...
(Date:7/23/2014)... Four hospitals affiliated with the Allegheny Health ... of the country’s best hospitals by U.S. News ... slated for publication in August, the U.S. News 2014-2015 ... Hospital, Saint Vincent Hospital and West Penn Hospital as ... , “There is no higher priority at Allegheny ...
Breaking Medicine News(10 mins):Health News:Rich Dad Education Charity Yard Sale Raises Over $650 for Habitat for Humanity of Lee and Hendry Counties 2Health News:Global Cardio Care Celebrates EECP Patient’s 100th Birthday 2Health News:Vote Now; BPI SPORTS is Nominated for Eight 2014 Bodybuilding.com Supplement Awards 2Health News:Vote Now; BPI SPORTS is Nominated for Eight 2014 Bodybuilding.com Supplement Awards 3Health News:Targeting the brain to treat obesity 2Health News:Targeting the brain to treat obesity 3Health News:Four Allegheny Health Network Hospitals Named High Performers by U.S. News 2Health News:Four Allegheny Health Network Hospitals Named High Performers by U.S. News 3
... Chem Rx (OTC,Bulletin Board: CHRX, CHRXU, CHRXW), a ... company ticker symbol has,changed to CHRX from PMQC. The ... trading community today., About Chem Rx Corporation, ... is a leading,provider of institutional pharmacy services in the ...
... SAN JOSE, Calif., April 18 VNUS(R) Medical,Technologies, Inc. ... has,received a Notice of Allowability by the U.S. Patent ... continuation of one of the three patents in,the VNUS ... The newly allowed VNUS patent application was filed as ...
... 18 AtriCure, Inc.,(Nasdaq: ATRC ), a medical device ... its financial results for the first quarter,ended March 31, 2008 ... conference call at 10:00 a.m. ET on Tuesday, May,6, 2008 ... of the,conference call will be available online from the investor ...
... connection between vitamin D level and the risk ... a long time, but its clinical relevance had ... from the working group headed by Dr. Jenny ... Krebsforschungszentrum, DKFZ), collaborating with researchers of the University ...
... LAKE CITY, April 18 Avalon Health Care, Inc. ... Lake City, Utah has,become the first skilled nursing facility ... Recognition (QRCR) from the American Association,for Respiratory Care (AARC)., ... by acute care,hospitals. This achievement reflects Avalon,s overall goal ...
... Changes in dopamine receptor density affects memory and psychomotor ... -- Long-term exposure to solvents in products such as ... the brain,s wiring, researchers report. , These abnormalities ... encephalopathy (CSE), the Dutch team conclude in the April ...
Cached Medicine News:Health News:Chem Rx Corporation Changes Ticker Symbol to CHRX 2Health News:U.S. Patent Office Allows Significant New VNUS Patent 2Health News:U.S. Patent Office Allows Significant New VNUS Patent 3Health News:AtriCure Announces Web Cast and Conference Call of First Quarter 2008 Financial Results 2Health News:Vitamin D and breast cancer risk 2Health News:Woodland Park Care Center Earns Quality Respiratory Care Recognition 2Health News:Chronic Exposure to Solvents Disturbs Brain's Wiring 2
The Karl Storz Videoscope offers maximum image quality and can be used in combination with standard documentation units. In contrast with conventional flexible endoscopes, images are displayed with ...
Exceptional illumination and realiability from this small source....
The 81483N projector operates off of DC power for maximum portability. The 20 watt halogen bulb with a specially designed reflector provides maximum brightness and portability....
Integrated electronics, single-chip CCD camera with PAL and NTSC output. PAL output at 625 lines, NTSC output at 525 lines. 23mm focal length. Output via Y/C mini-DIN-4 port. 135mm length x 44mm ...
Medicine Products: